Unknown

Dataset Information

0

Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.


ABSTRACT: Multidrug resistance is a serious problem and a common cause of cancer treatment failure, leading to patient death. Although numerous reversal resistance inhibitors have been evaluated in preclinical or clinical trials, efficient and low-toxicity reversal agents have not been identified. In this study, a series of novel quinoline compound derivatives from NSC23925 were designed to inhibit P-glycoprotein (P-gp). Among them, YS-7a showed a stronger inhibitory effect against P-gp than verapamil, as a positive control, when co-incubated with chemotherapy drugs at minimally cytotoxic concentrations. YS-7a suppressed the P-gp transport function without affecting the expression of P-gp but stimulated the ATPase activity of P-gp in a dose-dependent manner. Next, molecular docking was used to predict the six most probable binding sites, namely, SER270, VAL273, VAL274, ILE354, VAL357, and PHE390. Moreover, YS-7a had no effect on cytochrome P450 3A4 activity and showed little toxicity to normal cells. In addition, combined treatment of YS-7a with vincristine showed a better inhibitory effect than the positive control verapamil in vivo without a negative effect on mouse weight. Overall, our results showed that YS-7a could reverse cancer multidrug resistance through the inhibition of P-gp transport function in vitro and in vivo, suggesting that YS-7a may be a novel therapeutic agent.

SUBMITTER: Quan X 

PROVIDER: S-EPMC6931887 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.

Quan Xingping X   Du Hongzhi H   Xu Jingjing J   Hou Xiaoying X   Gong Xiaofeng X   Wu Yao Y   Zhou Yuqi Y   Jiang Jingwei J   Lu Ligong L   Yuan Shengtao S   Yang Xiangyu X   Shi Lei L   Sun Li L  

Frontiers in chemistry 20191219


Multidrug resistance is a serious problem and a common cause of cancer treatment failure, leading to patient death. Although numerous reversal resistance inhibitors have been evaluated in preclinical or clinical trials, efficient and low-toxicity reversal agents have not been identified. In this study, a series of novel quinoline compound derivatives from NSC23925 were designed to inhibit P-glycoprotein (P-gp). Among them, YS-7a showed a stronger inhibitory effect against P-gp than verapamil, as  ...[more]

Similar Datasets

| S-EPMC10762177 | biostudies-literature
| S-EPMC7016283 | biostudies-literature
| S-EPMC6084461 | biostudies-literature
| S-EPMC7221826 | biostudies-literature
| S-EPMC6109522 | biostudies-other
| S-EPMC3511002 | biostudies-literature
| S-EPMC5317256 | biostudies-literature
| S-EPMC3443622 | biostudies-literature
| S-EPMC6152673 | biostudies-literature
| S-EPMC7540715 | biostudies-literature